PROTOCOL RENAL ALLOGRAFT BIOPSY AS A CRITERION OF EXTRACORPOREAL PHOTOCHEMOTHERAPY EFFICIENCY
Abstract
THE AIM: is to analyze the histological results of the method extracorporeal photochemotherapy in cadaveric kidney allotransplantation. PATIENTS AND METHODS. Extracorporeal photochemotherapy has been used as a prevention of acute renal allograft rejection in the early postoperative period in 20 patients. The control group consisted of 20 patients with paired to basic group transplants without using of this method. Patients in both groups carried out the transplant protocol biopsies at 30 and 180 days after transplantation or when indicated, followed by the conclusion of histological classification according to the Banff 2007. Also showed a clinical case of the use of extracorporeal photochemotherapy as a therapy of transplant glomerulonephritis. RESULTS. It was established that in the basic group biopsy did not show any evidence of the transplant rejection, at the same time in 4 patients in comparison group histology confirmed rejection of the transplanted organ varying degrees of Banff 2007, two of which have resulted ingraft loss. Applications of extracorporeal photochemotherapy as the treatment of transplant glomerulonephritis showed that the method can be used to normalize graft function and is able to stop the development of focal and segmental glomerulosclerosis, that was confirmed by histological examination of a biopsy sample before and after treatment. CONCLUSION. Extracorporeal photochemotherapy is effective and can be used as adjuvant therapy for the prevention of renal allograft rejection and as a therapy of returned transplant glomerulonephritis.
About the Authors
V. A. FedulkinaRussian Federation
Veronica A. Fedulkina MD, PhD,
Senior Researcher of the Surgical department of Transplantation and Dialysis.
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 6.
A. V. Vatazin
Russian Federation
Andrey V. Vatazin, MD, PhD, Professor of medicine, DMedSci.
Head of the Department of Transplantation, Nephrology and Surgical hemocorrection.
Adress: 129110, Moscow, Shchepkin Str., 61/2, building 6.
A. V. Kildjushevskiy
Russian Federation
Alexander V. Kildushevskiy, Prof, MD, PhD, DMedSci.
Leading researcher of the department of Surgical hemocorrection and detoxifi cation.
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 11.
E. S. Stolyarevich
Russian Federation
Ekaterina S. Stolyarevich, MD,
Adress: 123182 Moscow, Russia. Pehotnaya str., d. 3
E. E. Kruglov
Russian Federation
Kruglov Evgeniy E., MD, Professor, Chief Physician
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 1
R. O. Kantariya
Russian Federation
Kantariya Rusudana O., PhD, physician-nephrologist of the Surgical department of Transplantation and Dialysis.
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 6
References
1. Ватазин АВ, Василенко ИА, Валов АЛ и др. Витальная компьютерная морфометрия лимфоцитов в диагностике острого отторжения почечного аллотрансплантата. Вестн трансплантол и искусственных органов 2009; 11(4): 18-26. [Vatazin AV, Vasilenko IA, Valov AL i dr. Vital'naja komp'juternaja morfometrija limfocitov v diagnostike ostrogo ottorzhenija pochechnogo allotransplantata. Vestnik transplantologii i iskusstvennyh organov 2009; 11(4): 18-26]
2. Cornell LD, Smith RN, Colvin RB. Kidney Transplantation: Mechanisms of Rejection and Acceptance. Annu Rev Pathol Mech Dis 2008;(3):189–220. doi: 10.1146/annurev.pathmechdis.
3. 121806.151508 3. Halloran PF, de Freitas DG, Einecke G et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010. (10):2223-2230. doi: 10.1111/j.1600-6143.2010.03268.x
4. Cornell LD, Smith RN, Colvin RB. Kidney Transplantation: Mechanisms of Rejection and Acceptance. Annu Rev Pathol Mech Dis 2008;(3):189–220. doi: 10.1146/annurev.pathmechdis. 3.121806.151508
5. Волынчик ЕП, Каабак ММ, Стенина ИИ и др. Некоторые аспекты изучения качества жизни реципиентов после трансплантации почки. Вестн трансплантол и искусственных органов 2009;11(4):26-30 [Volynchik EP, Kaabak MM, Stenina II i dr. Nekotorye aspekty izuchenija kachestva zhizni recipientov posle transplantacii pochki. Vestnik transplantologii i iskusstvennyh organov 2009;11(4):26-30]
6. Halloran PF, de Freitas DG, Einecke G et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010;(10):2223-2230. doi: 10.1111/j.1600-6143.2010.03268.x
7. Nafar M, Farrokhi F, Vaezi M et al. Pre-transplant and posttransplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection. Int Urol Nephrol 2008;(12):2114-2115. doi: 10.1007/s11255-008-9505-x
8. Cattaneo D, Baldelli S, Perico N. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises. Am J Transplant 2008;(8):1374. doi: 10.1111/j.1600-6143.2008.02263.x
9. Sahin G, Akay OM, Bal C et al. The effect of calcineurin inhibitors on endothelial and plateled function in renal transplant patients. Clinical Nephrology 2011;76(3):218-225. doi: 10.5414/ CN106931
10. Mohamed H, Sayegh MD, Laurence A et al. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998;338:1813-1821. doi: 10.1056/ NEJM199806183382506
11. Adamski J, Kinard T, Ipe T, Cooling L. Extracorporeal photopheresis for the treatment of autoimmune diseases. Transfus Apher Sci 2015;52(2):171-82. doi: 10.1016/j.transci.2015.02.005
12. Kenna KE, Whittaker S, Rhodes LE et al. Evidence – baced practice of photopheresis 1987 – 2001: a report of a workshop of the British Photodermatology group and the U.K. skin lymphoma group. Br J Dermatol 2006;154(1):7-20
13. Bulat V, Situm M, Dediol I et al. The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll Antropol 2011;35(2):147-151
14. Кильдюшевский АВ, Федулкина ВА, Фомина ОА, Фомин АМ. Применение экстракорпоральной фотохимиотерапии при лимфомах кожи и трансплантации солидных органов. Альманах клин мед 2014; (30): 61-69. [Kil'djushevskij AV, Fedulkina VA, Fomina OA, Fomin AM. Primenenie jekstrakorporal'noj fotohimioterapii pri limfomah kozhi i transplantacii solidnyh organov. Al'manah klinicheskoj mediciny 2014;( 30): 61-69]
15. Jung AG, Bertsch HP, Schoen MP, Lippert U. A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP). Hautarzt 2010;61(6):514-517. doi: 10.1007/s00105-010-1924-9
16. Kitko CL, Levine JE. Extracorporeal photopheresis in prevention and treatment of acute GVHD. Transfus Apher Sci 2015;52(2):151-156. doi: 10.1016/j.transci.2015.02.001
17. Radojcic V, Pletneva MA, Couriel DR. The role of extracorporeal photopheresis in chronic graft-versus-host disease Transfus Apher Sci 2015;52(2):157-161. doi: 10.1016/j.transci. 2015.02.002
18. Calore E, Marson P, Pillon M et al. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience. Biol Blood Marrow Transplant 2015; Nov;21(11):1963-1972. doi: 10.1016/j.bbmt.2015.07.007
19. Dieterlen MT, Bittner HB, Pierzchalski A et al. Immunological monitoring of extracorporeal photopheresis after heart transplantation. Clin Exp Immunol 2014 Apr;176(1):120-128. doi: 10.1111/cei.12254
20. Barten MJ, Dieterlen MT. Extracorporeal photopheresis after heart transplantation. Immunotherapy 2014;6(8):927-944. doi: 10.2217/imt.14.69
21. Rummler S, Barz D. Extracorporeal photopheresis – a benefical treatment for cardiac and lung transplant rejection. Transplant international 2011;(24):5. doi: 10.2217/imt.14.69
22. Urbani L, Mazzoni A, Colombatto P et al. Potential applications of extracorporeal photopheresis in liver transplantation Transplant Proc 2008 May;40(4):1175-1178. doi: 10.1016/j. transproceed.2008.03.071
23. Roberto Dall’ et al. Successful Treatmentof Recurrent Rejection in Renal Transplant Patients with Photopheresis. J Am Soc Nephrol 1998 Jan;9(1):121-127
24. Baron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001;(17):79–82
25. Fernandez EJ, Lopez C, Ramirez A et al. Role of photopheresis in the treatment of refractory cellular rejection in kidney transplantation. Nefrologia 2016 May-Jun;36(3):327-328. doi: 10.1016/j.nefro.2015.06.023
26. Lai Q, Pretagostini R, Gozzer M et al. Multimodal treatment for acute antibody-mediated renal transplant rejection: successful rescue therapy with combined plasmapheresis, photopheresis and intravenous immunoglobulin. G Ital Nefrol 2012 Jan-Feb;29(54):S31-35
27. Jardine MJ, Bhandari S, Wyburn KR et al. Photopheresis Therapy for Problematic Renal Allograft Regection. J Clin Apher 2009;24(4):161-169. doi: 10.1002/jca.20199
28. Lamioni A, Carsetti R, Legato A et al. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipient. Transplantation 2007 May 27;83(10):13931396
29. Genberg H, Kumlien G, Shanwell A, Tyden G. Refractory acute renal allograft rejection successfully treated with photopheresis. Transplant Proc 2005 Oct;37(8):3288-3289
30. Kusztal M, Kościelska-Kasprzak K, Gdowska W et al. Extracorporeal photopheresis as an antirejection prophylaxis in kidney transplant recipients: preliminary results. Transplant Proc 2011 Oct;43(8):2938-2940. doi: 10.1016/j.transproceed.2011.08.061
31. Kusztal M, Kłak R, Krajewska M et al. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Transplant Proc 2011 Oct;43(8):2941-2942. doi: 10.1016/j.transproceed.2011.08.034
32. Траилин АВ, Никоненко ТН, Никоненко АС. Обзор материалов Банфф-конференции 2011 года. Вестн трансплантол и искусственных органов 2012;(1):114-122 [Trailin AV, Nikonenko TN, Nikonenko AS. Obzor materialov Banff – konferencii 2011 goda. Vestnik transplantologii i iskusstvennyh organov 2012;(1):114-122]
33. Solez K, Colvin RB, Racusen LS et al. Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions. Am J Transplant 2008 Apr;8(4):753-760. doi: 10.1111/j.16006143.2008.02159.x
34. Schmid D, Grabmer C, Streif D et al. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang. 2015 Jan;108(1):82-88. doi: 10.1111/vox.12200
35. Ватазин АВ, Зулькарнаев АБ, Кильдюшевский АВ и др. Некоторые механизмы дей ствия экстракорпоральной фотохимиотерапии при трансплантации солидных органов. Вестн трансплантол и искусственных органов 2014;16(1):7684. [Vatazin AV, Zul'karnaev AB, Kil'djushevskij AV i dr. Nekotorye mehanizmy dejstvija jekstrakorporal'noj fotohimioterapii pri transplantacii solidnyh organov. Vestnik transplantologii i iskusstvennyh organov 2014;16(1):76-84]
36. Ibernon M, Goma M, Moreso F. et al. Subclinical rejection impairs glomerular adaptation after renal transplantation. Kidney Int 2006 Aug;70(3):557-561 37. Сухоруков ВА, Юшинскис ЯЛ, Штрумфа И, Розенталь РЛ. Значение протокольных биопсий в раннем периоде после трансплантации почки. Вестн трансплантол и искусственных органов 2010;12(4):33-36 [Suhorukov VA, Jushinskis JaL, Shtrumfa I, Rozental' RL. Znachenie protokol'nyh biopsij v rannem periode posle transplantacii pochki. Vestnik transplantologii i iskusstvennyh organov 2010;12(4):33-36]
Review
For citations:
Fedulkina V.A., Vatazin A.V., Kildjushevskiy A.V., Stolyarevich E.S., Kruglov E.E., Kantariya R.O. PROTOCOL RENAL ALLOGRAFT BIOPSY AS A CRITERION OF EXTRACORPOREAL PHOTOCHEMOTHERAPY EFFICIENCY. Nephrology (Saint-Petersburg). 2016;20(6):57-66. (In Russ.)